Bremelanotide for Hypoactive Sexual Desire Disorder: Contraceptive Subgroups Efficacy Analysis

被引:0
|
作者
Clayton, Anita [6 ]
Kingsberg, Sheryl [5 ]
Simon, James [2 ,3 ]
Jordan, Robert [4 ]
Williams, Laura [1 ]
Krop, Julie [1 ]
机构
[1] AMAG Pharmaceut Inc, Waltham, MA USA
[2] George Washington Univ, Washington, DC USA
[3] IntimMed Specialists, Washington, DC USA
[4] Palatin Technol Inc, Cranbury, NJ USA
[5] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
[6] Univ Virginia, Charlottesville, VA USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
20
引用
收藏
页码:8 / 8
页数:1
相关论文
共 50 条
  • [1] BREMELANOTIDE FOR HYPOACTIVE SEXUAL DESIRE DISORDER: CONTRACEPTIVE SUBGROUPS EFFICACY ANALYSIS
    Clayton, A.
    Kingsberg, S.
    Simon, J.
    Jordan, R.
    Williams, L.
    Krop, J.
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (01): : S67 - S67
  • [2] Efficacy of Bremelanotide Across Hypoactive Sexual Desire Disorder Duration Subgroups
    Simon, James A.
    Clayton, Anita H.
    Kingsberg, Sheryl
    Jordan, Robert
    Williams, Laura
    Krop, Julie
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 144S - 145S
  • [3] EFFICACY OF BREMELANOTIDE FOR HYPOACTIVE SEXUAL DESIRE DISORDER (RECONNECT STUDY)
    Kingsberg, Sheryl
    Lucas, John
    Jordan, Robert
    Spana, Carl
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (05): : E335 - E335
  • [4] Bremelanotide for Hypoactive Sexual Desire Disorder in the RECONNECT Studies: Analysis of Baseline Arousal Subgroups
    Kingsberg, Sheryl
    Clayton, Anita
    Simon, James
    Jordan, Robert
    Lucas, Johna
    Williams, Laura
    Krop, Julie
    JOURNAL OF WOMENS HEALTH, 2019, 28 (06) : 22 - 22
  • [5] Bremelanotide (Vyleesi) for Hypoactive Sexual Desire Disorder
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1577): : 114 - 116
  • [6] Bremelanotide for Hypoactive Sexual Desire Disorder: Age and Weight Subgroup Efficacy Analyses
    Simon, James A.
    Kingsberg, Sheryl A.
    Clayton, Anita H.
    Jordan, Robert
    Lucas, Johna
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 184S - 184S
  • [7] Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
    Simon, James A.
    Kingsberg, Sheryl A.
    Portman, David
    Williams, Laura A.
    Krop, Julie
    Jordan, Robert
    Lucas, Johna
    Clayton, Anita H.
    OBSTETRICS AND GYNECOLOGY, 2019, 134 (05): : 909 - 917
  • [8] ELEMENTS OF DESIRE QUESTIONNAIRE ASSESSMENT OF BREMELANOTIDE EFFICACY FOR HYPOACTIVE SEXUAL DESIRE DISORDER IN THE RECONNECT STUDY
    Revicki, D.
    Althof, S.
    DeRogatis, L.
    Kingsberg, S.
    Wilson, H.
    Jordan, R.
    Lucas, J.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (06): : S99 - S99
  • [9] Elements of desire questionnaire assessment of bremelanotide efficacy for hypoactive sexual desire disorder in the reconnect studies
    Clayton, A.
    Althof, S.
    DeRogatis, L.
    Kingsberg, S.
    Wilson, H.
    Jordan, R.
    Johna, L.
    Revicki, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S403 - S404
  • [10] An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder
    Cipriani, Sarah
    Alfaroli, Chiara
    Maseroli, Elisa
    Vignozzi, Linda
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (01) : 15 - 21